NCT07528352 External Beam Radiotherapy Followed by Bispecific Antibody Therapy for Relapsed/Refractory DLBCL Status NOT_YET_RECRUITING Phase PHASE1
NCT07502872 TPG: Tafasitamab, Polatuzumab Vedotin, and Glofitamab as First-line Therapy for Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma Status NOT_YET_RECRUITING Phase PHASE2
NCT07476105 Geriatric-guided Care Versus Conventional Care in Elderly Unfit/Frail Patients With Diffuse Large B-cell Lymphoma in First Line Treatment Status NOT_YET_RECRUITING Phase NA
NCT07368270 Safety and Efficacy Study of Anti-PD1 Armored CD19 CAR-T Cells in Adult Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma Status RECRUITING Phase PHASE1
NCT07225439 Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL) Status NOT_YET_RECRUITING Phase PHASE1
NCT06829771 Clinical Trial of TQB2825 Injection Combined Immunochemotherapy in Subjects With Diffuse Large B Cell Lymphoma Status RECRUITING Phase PHASE1/PHASE2
NCT06768905 IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL Status RECRUITING Phase PHASE1/PHASE2
NCT06736613 A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma Status RECRUITING Phase PHASE2
NCT06694779 Thrombosis in Diffuse Large B-cell Lymphoma:the PREDIC-TO (PREDICt ThrOmbosis) Study Status RECRUITING Phase N/A
NCT06687772 CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant Status RECRUITING Phase PHASE2
NCT06669143 Zanubrutinib-based Maintenance Therapy of Newly Diagnosed DLBCL With Initial Remission Status NOT_YET_RECRUITING Phase PHASE2
NCT06652139 Selinexor Combined With BEAM for ASCT in R/R DLBCL With MYC Positive Status NOT_YET_RECRUITING Phase PHASE2
NCT06625203 A Non-interventional, International, Multicentre Clinical Research Study to Build the Largest Collection of Multimodal Data (Including Clinical Data, Imaging Data and Omics Data) in Oncology Status RECRUITING Phase N/A
NCT06589089 Autologous Hematopoietic Stem Cell Boost Study After CAR-T Therapy Status RECRUITING Phase PHASE2
NCT06588205 Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma Status RECRUITING Phase N/A
NCT06552572 Glofitamab in Relapsed or Refractory Diffuse Large B-cell Lymphoma After CD19 Chimeric Antigen Receptor T-cell Therapy Status ACTIVE_NOT_RECRUITING Phase PHASE2